Cleared Traditional

K193194 - CrossTorq 14 Guidewire

K193194 is the FDA 510(k) clearance for CrossTorq 14 Guidewire by Scientia Cardio Access, LLC. It is a Class 2 Cardiovascular device (product code DQX) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2019
Decision
24d
Days
Class 2
Risk

K193194 is an FDA 510(k) clearance for the CrossTorq 14 Guidewire. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Scientia Cardio Access, LLC (West Valley City, US). The FDA issued a Cleared decision on December 13, 2019 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Scientia Cardio Access, LLC devices

Submission Details

510(k) Number K193194 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 19, 2019
Decision Date December 13, 2019
Days to Decision 24 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 125d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Prithul Bom

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DQX Wire, Guide, Catheter

All 501
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K193194.
Wattson Temporary Pacing Guidewire
K192454 · Vascular Solutions · Jan 2020
OptoWire III
K191907 · Opsens, Inc. · Jan 2020
ASAHI PTCA Guide Wire ASAHI Gaia Next
K192599 · Asahi Intecc Co., Ltd. · Jan 2020
HI-TORQUE InfilTrac Guide Wire Family
K193126 · Abbott Vascular · Dec 2019
Heraeus Peripheral Guidewire
K191502 · Heraeus Medical Components, LLC · Nov 2019
Asahi PTCA Guide Wire Asahi SION Series
K191464 · Asahi Intecc Co., Ltd. · Nov 2019